[1]
Piccaluga, P. 2009. Palonosetron, second generation 5-HT3 antagonist: a new perspective in CINV management. Hematology Meeting Reports (formerly Haematologica Reports). 2, 7 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i7.414.